Cohort information

ITALY				WP5
Organization		University of Padova (UNIPD)
Name of cohort		PADOVA
Referring partner		UNIVR
Cohort Information	Country(-ies), cities, regions or centers involved	Padova, Italy
	Time of data collection	12/2020	11/2024
	Enrolment	Inactive
	Study setting	Single center
Population	Age	Adults
	Type	Retrospective
	Total number of patients	8511
Data collection	Clinical data	True
	Serological data	True
	Genetic data	False
	Sample collection	True
	Sample collected	Whole blood	No
		PBMC	Yes
		Dry-spot blood	No
		Plasma	No
		Serum	Yes
		Stool	No
		NP swabs	Yes
		Other	Salivary swabs
Description	The cohort consists of over six thousand healthcare workers from the University Hospital of Padova, stratified by gender, age and job title. The subjects are vaccinated against SARS-CoV-2 and periodically tested with nasopharyngeal or salivary swabs. Subjects were also tested once with serology test between 1-3 months after the third dose of SARS-CoV-2 vaccine (approximately 1 year after the first dose). Clinical data were collected via online questionnaire.
Publications	- SARS-CoV-2 and Its Variants in Thrice-Infected Health Workers: A Case Series from an Italian University Hospital [Viruses] - Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern [International Journal of Molecular Sciences] - Effectiveness of prevention of SARS-CoV-2 transmission among unvaccinated Italian healthcare workers [La Medicina del Lavoro] - Perceived Psychological Impact on Children and Parents of Experiencing COVID-19 Infection in One or More Family Members [Children] - SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know [Transplant International] - When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19 [Frontiers in Public Health] - Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study [PLOS One]